Search
Menu
Home
HTB
2020
January
January 2020
Contents
Editorial
HTB 29 January 2020 online
Supplements
i-Base guide to HIV testing and sexual transmission (January 2020)
Antiretrovirals
FDA decision on long-acting cabotegravir/rilpivirine (Cabenuva, Vocabria) injections delayed due to scale-up manufacturing problems
Fostemsavir submitted to EMA for treating multidrug resistant HIV
Gilead announces licensing agreement for Rockefeller University bNAbs
PK and drug interactions
Updates to Liverpool University drug interactions website
Guidelines
US HIV Guidelines updated (December 2019)
BHIVA 2019 audit shows early access to ART but U=U and peer support both need to be improved
Vaccines and microbicides
FluAGE study supports BHIVA recommendations for HIV positive people to have annual flu shot
PDFs
29 January 2020 vol 21 no 1
HTB RSS
Early access
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
All early access reports
Current issues
April 2025
March 2025
February 2025
Back issues
Special report
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate